Adline Chem Lab Share Price
12.12+0.00 (+0.00%)
-32.48% past 1 Year
Kamron Laboratories Ltd was established in the year 1990 to produce tablets, capsules and liquid orals at Rakanpur near Ahmedabad. They have been among the pioneer members of various trade
Corporate filings & documents
Announcements
Annual Report of the Company for the Financial Year 2025-26 along with the Notice of 38th Annual General Meeting to be held on Monday September 28 2026 at 02:00 P.M. through Video Conference ("VC")/Other Audio Visual Means ("OAVM")
20 hours agoAnnual Report of the Company for the Financial Year 2025-26 along with the Notice of 38th Annual General Meeting to be held on Monday September 28 2026 at 02:00 P.M. through Video Conference ("VC")/Other Audio Visual Means ("OAVM")
20 hours agoNotice of 38th Annual General Meeting of Adline Chem Lab Limited.
20 hours agoNotice of 38th Annual General Meeting of Adline Chem Lab Limited.
20 hours agoOutcome for Board Of Directors Meeting Held On Tuesday 01st September 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
2 days agoOutcome for Board Of Directors Meeting Held On Tuesday 01st September 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
2 days agoConvening of the 38th Annual General Meeting (AGM) and other allied matters.
1 week agoConvening of the 38th Annual General Meeting (AGM) and other allied matters.
1 week agoAdline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2026 inter alia to consider and approve the day date time of 38th Annual General Meeting and allied matters
1 week agoAdline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2026 inter alia to consider and approve the day date time of 38th Annual General Meeting and allied matters
1 week agoNewspaper Advertisment for Extract of Unaudited Standalone Financial Results for the Quarter ended 30th June 2026.
3 weeks agoNewspaper Advertisment for Extract of Unaudited Standalone Financial Results for the Quarter ended 30th June 2026.
3 weeks agounaudited Stanalone Financial Results of the Company for the Quarter Ended June 30 2026.
3 weeks agounaudited Stanalone Financial Results of the Company for the Quarter Ended June 30 2026.
3 weeks agoBoard Meeting Outcome for Adline Chem Lab Limited for Unaudited Standalone Financial Results For The Quarter Ended June 30 2026.
3 weeks agoBoard Meeting Outcome for Adline Chem Lab Limited for Unaudited Standalone Financial Results For The Quarter Ended June 30 2026.
3 weeks agoAdline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Un-audited Standalone Financial Results for the Quarter ended June 2026.
3 weeks agoAdline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Un-audited Standalone Financial Results for the Quarter ended June 2026.
3 weeks agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended on June 30 2026.
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended on June 30 2026.
1 month agoIntimation for Closure of Trading Window
2 months agoIntimation for Closure of Trading Window
2 months agoIntimation of Resignation of Independent Directors
2 months agoIntimation of Resignation of Independent Directors
2 months agoEnclosed
3 months agoEnclosed
3 months agoFinancial Results for 31.03.2026
3 months agoAudited Standalone Financial Results of the Company for the Quarter and Financial Year Ended 31.03.2026.
3 months agoAudited Standalone Financial Results of the Company for the Quarter and Financial Year Ended 31.03.2026.
3 months agoAdline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Audited Standalone Financial Results for the quarter and Financial Year ended March 31 2026.
3 months agoAdline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Audited Standalone Financial Results for the quarter and Financial Year ended March 31 2026.
3 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Adline Chem Lab Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24231GJ1988PLC010956</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>FY 2024-25 25-26</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>FY 2023-24 24-25</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Gopika Mukesh Gokani</td></tr><tr><td>Designation :-</td><td>Company Secretary</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Hardik Jitendrabhai Vaghasiya</td></tr> <tr><td>Designation : -</td><td>Chief Financial Officer</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>
4 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Adline Chem Lab Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24231GJ1988PLC010956</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>FY 2024-25 25-26</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>FY 2023-24 24-25</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Gopika Mukesh Gokani</td></tr><tr><td>Designation :-</td><td>Company Secretary</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Hardik Jitendrabhai Vaghasiya</td></tr> <tr><td>Designation : -</td><td>Chief Financial Officer</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Adline Chem Lab Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24231GJ1988PLC010956</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>1.73</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Gopika Mukesh Gokani <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Hardik JItendrabhai Vaghasiya <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Adline Chem Lab Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24231GJ1988PLC010956</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>1.73</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Gopika Mukesh Gokani <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Hardik JItendrabhai Vaghasiya <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoNon-Applicability of Annual Secretarial Compliance Report for the year ended March 31 2026.
4 months agoVoting Results of Postal Ballot
4 months agoVoting Results of Postal Ballot
4 months agoCertificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st March 2026.
4 months agoPursuant to Reg.30 of SEBI (LODR) Regulations 2015 the board of Directors at its meeting held on 02.04.2026 approved the appointment of Ms. Gokani Gopika Mukesh as the Company Secretary and Comliance Officer of the Company w.e.f. 02.04.2026.
5 months agoPursuant to Reg.30 of SEBI (LODR) Regulations 2015 the board of Directors at its meeting held on 02.04.2026 approved the appointment of Ms. Gokani Gopika Mukesh as the Company Secretary and Comliance Officer of the Company w.e.f. 02.04.2026.
5 months agoAppointment of Company Secretary and Compliance Officer
5 months agoAppointment of Company Secretary and Compliance Officer
5 months agoClosure of Trading Window.
5 months agoClosure of Trading Window.
5 months agoNewspaper Advertisement with respect to Postal Ballot Notice and remote e-voting.
5 months agoPostal Ballot Notice Dated 19.03.2026.
5 months agoPostal Ballot Notice Dated 19.03.2026.
5 months agoOutcome of Board Meeting for approval via Postal Ballot for the appointment of Mr. Vrushank Balkrushna Patel (DIN: 05310613) as the Chairman and Managing Director of the Company.
5 months agoNewspaper Advertisement of Extract of Unaudited Financial Results for the Quarter and Nine Months ended on 31st December 2025.
6 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
A - 514, Stellar Opp. Arista Building Sindhu Bhavan Road, Bodakdev Ahmedabad Gujarat PIN: 380054 Tel No: 09227510541 Fax No: 02764- 286038 Email: [email protected] Internet: www.kamronlabs.com
Registrars
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I)Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura, Ahmedabad - 380009 506-508, 5th Floor, Amaranth Business Complex - I (ABC - I) Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road Navrangpura PIN: Tel No: NULL Fax No: NULL Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Vrushank Balkrushna Patel, Executive Non Independent Director
Nilay Jitendrabhai Vaghasiya, Executive Non Independent Director
Dhawal Akhilesh Deopura, Non Executive Independent Director
Sarang Pathak, Managing Director
Shivani Pathak, Non Executive Independent Director
Gokani Gopika Mukesh, Company Secretary and Compliance Officer
Details
BSE 524604
NSE NULL
ISIN INE276T01018